Functional role of vitronectin in breast cancer
Fig 4
Recurrence and vitronection concentration level in serum.
A. Overall concentration level of vitronectin in 21 recurrence samples (n = 21) and compared serum vitronectin concentration levels to 21 non-recurrence samples of same IHC sub-groups. B. Receiver Operation Characteristic (ROC) Curve and, the statistical evaluation of vitronectin concentration in serum samples between non-recurrence vs recurrence patients. We tested to see if vitronectin could be used as a recurrence biomarkers and, we found that the area under curve (AUC) is 0.7107 with a p-value 0.0940.